PTSD (Post-Traumatic Stress Disorder): Definition, Clinical Context, and Key Facts

Post-Traumatic Stress Disorder (PTSD) is a trauma- and stressor-related disorder that develops in some individuals after exposure to actual or threatened death, serious injury, or sexual violence. According to the DSM-5-TR, exposure can occur through direct experience, witnessing the event in person, learning that the traumatic event occurred to a close family member or friend, or repeated exposure to aversive details of traumatic events (as in first responders). PTSD is characterized by persistent re-experiencing of the trauma, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and marked changes in arousal and reactivity — lasting more than one month and causing clinically significant distress or functional impairment.

PTSD is classified under Trauma- and Stressor-Related Disorders in the DSM-5-TR, distinguishing it from anxiety disorders where it was previously categorized. The DSM-5-TR organizes its diagnostic criteria into four symptom clusters:

• Intrusion symptoms: Recurrent, involuntary distressing memories, nightmares, flashbacks, or intense psychological or physiological distress when exposed to trauma-related cues.
• Avoidance: Persistent efforts to avoid internal reminders (thoughts, feelings) and external reminders (people, places, activities) associated with the traumatic event.
• Negative alterations in cognition and mood: Distorted blame of self or others, persistent negative emotional states, feelings of detachment, or inability to recall key aspects of the trauma.
• Alterations in arousal and reactivity: Irritability, hypervigilance, exaggerated startle response, concentration difficulties, and sleep disturbance.

The NIMH estimates that approximately 6% of the U.S. population will experience PTSD at some point in their lifetime, with 12-month prevalence among adults estimated at roughly 3.6%. Women are approximately twice as likely as men to develop PTSD. Onset can occur at any age, including childhood, and the DSM-5-TR includes a specific subtype for children six years and younger. A dissociative subtype — marked by depersonalization or derealization — is also recognized.

In clinical practice, PTSD frequently co-occurs with major depressive disorder, substance use disorders, anxiety disorders, and traumatic brain injury. Accurate assessment requires careful differential diagnosis to distinguish PTSD from acute stress disorder, adjustment disorders, and other conditions with overlapping symptoms.

• Acute Stress Disorder (ASD): A related condition with similar symptom presentation occurring within 3 days to 1 month after trauma exposure. Not all individuals with ASD develop PTSD, but ASD is a significant risk factor.
• Complex PTSD (C-PTSD): Recognized by the ICD-11 (though not a formal DSM-5-TR diagnosis), C-PTSD describes patterns associated with prolonged, repeated trauma — particularly in interpersonal contexts — and includes additional features such as affect dysregulation, negative self-concept, and disturbances in relationships.
• Trauma-Informed Care: A clinical framework that recognizes the widespread impact of trauma and integrates this understanding into all aspects of service delivery.
• Moral Injury: An emerging concept describing the psychological distress resulting from actions, or the witnessing of actions, that violate an individual's moral code — often discussed alongside PTSD in military and first-responder populations.

PTSD is one of the most extensively researched psychiatric conditions, with strong evidence supporting several treatment approaches including trauma-focused cognitive-behavioral therapy (TF-CBT), cognitive processing therapy (CPT), prolonged exposure (PE), and eye movement desensitization and reprocessing (EMDR). Pharmacotherapy — particularly selective serotonin reuptake inhibitors (SSRIs) — is also supported by clinical evidence. Early identification and evidence-based intervention are critical, as untreated PTSD is associated with substantial impairment in occupational, social, and physical health domains, elevated suicide risk, and high healthcare utilization. Clinicians should screen for trauma history routinely, as many individuals do not spontaneously disclose traumatic experiences.

If you or someone you know experiences persistent intrusive memories, nightmares, emotional numbness, hypervigilance, or avoidance behaviors following a traumatic event — especially when these patterns last more than a month and interfere with daily functioning — a professional evaluation by a qualified mental health provider is strongly recommended. PTSD is a treatable condition, and early intervention improves outcomes.